Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Asymmetrical sero-negative thyroid associated ophthalmopathy in a hypothyroid patient.

Naik M, Bhat T, Naqash M, Yusuf I, Ali I, Qadri M, Wani M.

Indian J Endocrinol Metab. 2013 Mar;17(2):363-4. doi: 10.4103/2230-8210.109692. No abstract available.

2.

Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy.

Eckstein AK, Lösch C, Glowacka D, Schott M, Mann K, Esser J, Morgenthaler NG.

Br J Ophthalmol. 2009 Aug;93(8):1052-6. doi: 10.1136/bjo.2007.137265.

PMID:
19221109
3.

Autoantibodies to the flavoprotein subunit of succinate dehydrogenase: analysis of specificity in autoimmune thyroid disease.

Kemp EH, Ridgway JN, Smith KA, Watson PF, Weetman AP.

Clin Endocrinol (Oxf). 2000 Sep;53(3):291-9.

PMID:
10971445
4.

Rituximab therapy in steroid-resistant severe hypothyroid Grave's ophthalmopathy.

Pandit A, Gundgurthi A, Kharb S, Brar KS, Garg MK.

Indian J Endocrinol Metab. 2013 Mar;17(2):344-8. doi: 10.4103/2230-8210.109669.

5.

[A case of Hypothyroid Graves' disease with extremely high titers of TSAb].

Nakai M, Okada Y, Tanikawa T, Kanda K, Morita E, Tanaka Y.

J UOEH. 2003 Sep 1;25(3):333-9. Japanese.

PMID:
14503045
6.

Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic.

Perros P, Crombie AL, Matthews JN, Kendall-Taylor P.

Clin Endocrinol (Oxf). 1993 Apr;38(4):367-72.

PMID:
8319368
7.

Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.

Prummel MF, Wiersinga WM, Mourits MP, Koornneef L, Berghout A, van der Gaag R.

Arch Intern Med. 1990 May;150(5):1098-101.

PMID:
1691908
8.

Clinical features and treatment of graves ophthalmopathy in pediatric patients.

Durairaj VD, Bartley GB, Garrity JA.

Ophthal Plast Reconstr Surg. 2006 Jan-Feb;22(1):7-12.

PMID:
16418658
9.

Graves' ophthalmopathy and 131I therapy.

Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Mazzi B, Rocchi R, Barbesino G, Pinchera A.

Q J Nucl Med. 1999 Dec;43(4):307-12. Review.

PMID:
10731781
10.

Asymmetric ophthalmopathy in a hypothyroid patient.

Taylor T, Czarnowski C.

Can Fam Physician. 2007 Apr;53(4):635, 637-8. No abstract available.

11.
12.

Thyroid-associated ophthalmopathy in Iranian patients.

Kashkouli MB, Jam S, Sabzvari D, Ketabi N, Azarinia S, SeyedAlinaghi S, Mofid A.

Acta Med Iran. 2011;49(9):612-8.

13.

[Thyroid ophthalmopathy: clinical activity determination of thyroid ophthalmopathy as a prognostic factor of immunosuppressive treatment response].

Belzunce-Manterola A, García-Gómez PJ, Casellas-Bravo M, Heras-Mulero H, Moreno-Montañés J.

Arch Soc Esp Oftalmol. 2005 Dec;80(12):705-12. Spanish.

PMID:
16372213
14.

Natural history of thyroid associated ophthalmopathy.

Perros P, Crombie AL, Kendall-Taylor P.

Clin Endocrinol (Oxf). 1995 Jan;42(1):45-50.

PMID:
7889631
15.
16.

Antibodies to orbital tissues in thyroid-associated ophthalmopathy.

Perros P, Kendall-Taylor P.

Acta Endocrinol (Copenh). 1992 Feb;126(2):137-42.

PMID:
1543019
18.

Correlation of orbital muscle changes evaluated by magnetic resonance imaging and thyroid-stimulating antibody in patients with Graves' ophthalmopathy.

Nishikawa M, Yoshimura M, Toyoda N, Masaki H, Yonemoto T, Gondou A, Kato T, Kurokawa H, Furumura T, Inada M.

Acta Endocrinol (Copenh). 1993 Sep;129(3):213-9.

PMID:
8105634
19.

Endocrine ophthalmopathy: a re-evaluation of the association with thyroid autoantibodies.

McLachlan SM, Bahn R, Rapoport B.

Autoimmunity. 1992;14(2):143-8.

PMID:
1363894
20.

Nature of 64 kDa eye muscle and thyroid membrane proteins and their significance in thyroid-associated ophthalmopathy--an hypothesis.

Boucher A, Bernard N, Zhang ZG, Rodien P, Salvi M, Wall JR.

Autoimmunity. 1993;16(2):79-82. Review.

PMID:
8180320
Items per page

Supplemental Content

Support Center